Search Press releases Keywords From To 21 May 2018 UCB joins with ILAE and IBE to encourage World Health Assembly members to continue recognition of epilepsy as global health priority Read More 15 May 2018 CIMZIA® (certolizumab pegol) is The First Therapy to Demonstrate Positive Results in a 52-week, Placebo Controlled Non-Radiographic Axial Spondyloarthritis Study Read More 13 May 2018 UCB announces BRIVIACT® (brivaracetam) now approved by FDA to treat partial-onset (focal) seizures in pediatric epilepsy patients Read More 10 May 2018 UCB to present latest epilepsy scientific data and research perspectives at EILAT Conference Read More 27 Apr 2018 UCB Announces Positive CHMP Opinion for CIMZIA® (certolizumab pegol) in Patients with Moderate-to-Severe Plaque Psoriasis Read More 26 Apr 2018 UCB's General Meeting of Shareholders Read More Pagination First page Previous page Previous … Page 70 Page 71 Page 72 Page 73 Current page 74 Page 75 Page 76 Page 77 Page 78 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
